Skip to content
Contents

3B. Manufacture of laboratory-developed tests

Feedback & support
Amended

Last amended by an amending law of 2021. 2 amendments in all.

(1)

A person licensed under the Healthcare Services Act 2020 to provide any of the following licensable healthcare services may manufacture a laboratory-developed test without holding a manufacturer’s licence under section 12(1) of the Act, if the person manufactures the laboratory-developed test solely for the provision of that licensable healthcare service:

(a)

a clinical laboratory service;

(b)

a nuclear medicine assay service;

(c)

a blood banking service;

(d)

a cord blood banking service.

(2)

A person mentioned in paragraph (1) is subject to the duties and obligations of a manufacturer of a medical device under regulations 33(a), 38, 39, 41, 42, 44, 45, 46 and 47.

Subregulation 1

A person licensed under the Healthcare Services Act 2020 to provide any of the following licensable healthcare services may manufacture a laboratory-developed test without holding a manufacturer’s licence under section 12(1) of the Act, if the person manufactures the laboratory-developed test solely for the provision of that licensable healthcare service:

(a)

a clinical laboratory service;

(b)

a nuclear medicine assay service;

(c)

a blood banking service;

(d)

a cord blood banking service.

Subregulation 2

A person mentioned in paragraph (1) is subject to the duties and obligations of a manufacturer of a medical device under regulations 33(a), 38, 39, 41, 42, 44, 45, 46 and 47.

Report